Fast Locator 2011-2012: PharmaCore, Inc. - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Fast Locator 2011-2012: PharmaCore, Inc.


Since 2000, PharmaCore has performed a variety of chemistry services for leading pharmaceutical and biotechnology companies including: custom organic synthesis; cGMP scale-up; development of novel molecular building blocks; chemical process research and development; and medicinal chemistry services.

Custom Organic Synthesis
Custom organic synthesis is one of the things PharmaCore does best.

PharmaCore’s chemists can synthesize new compounds rapidly, keeping your research on track. For the large pharmaceutical company, that means supplementing your world-class research programs. For smaller companies, PharmaCore can serve as your off-site “chemistry department.”

With increasing dependence of the industry on outsourcing synthetic chemistry, large pharmaceutical companies and emerging drug discovery companies come to PharmaCore to turn multiple synthesis steps with marginal yields into practical chemistry with higher yields.

GMP Manufacturing
PharmaCore has developed an outstanding state-of-the-art facility to serve the growing need for GMP clinical material and bulk active pharmaceutical ingredients (APIs) accompanying the rapid pace of drug discovery.

PharmaCore's new GMP manufacturing facility features five new production suites. The plant is designed with maximum versatility with process conditions of -70 to 160+°, glass and Hastelloy, computer monitoring and flexible equipment configurations. Reactors with process volumes from 2000 liters to laboratory scale are ready to supply your clinical needs.

GMP Analytical
PharmaCore's new GMP analytical laboratories are equipped with the most up-to-date instrumentation to serve your analytical needs, including ICH Q1A-compliant stability chambers. Our services include: analytical methods development/validation/transfer; analytical methods improvement; ICH stability studies, storage and testing; reference standard qualification; and product release/retain. Our seasoned team of scientists brings a wealth of pharmaceutical industry experience to your project.


Our continued success is due to our competitive pricing, our unwavering commitment to customer service and to the talent and experience of our scientists.


Regions where services are provided:

North America, Europe, Asia (global)


Outsourcing serivces provided:

Development and Phase I/IICTM

  • Process development-small molecule

Commercial Manufacturing

  • API and advanced intermediates (GMP, small molecules)

Analytical Services

  • Chemistry and stability

API Production Technologies

  • Acetylenic chemistry
  • Acid chlorides
  • Acylation
  • Amidation
  • Amino acids and analogs
  • Azide chemistry
  • Borane chemistry
  • Bromine chemistry/bromination
  • Carbohydrate chemistry
  • Heterocyclic chemistry
  • Fluorination
  • Hydrazine chemistry
  • Nitration
  • Organometallic chemistry
  • Phosgenation
  • Sulfonation

Website:

www.pharmacore.com

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
19%
To all process for new products only
14%
To select process for new products only
24%
To select processes for both new and legacy products
19%
Do not use QbD
24%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
Overcoming the Challenges in Biopharmaceutical Stability Testing
PhRMA Dismayed by Special 301 Report
FindPharma Custom Search

Click here